220 related articles for article (PubMed ID: 18499568)
1. Sublingual immunotherapy.
Frew AJ
N Engl J Med; 2008 May; 358(21):2259-64. PubMed ID: 18499568
[No Abstract] [Full Text] [Related]
2. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy.
Wilkinson J
Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357
[No Abstract] [Full Text] [Related]
3. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment.
Durham SR
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():121-7; discussion 127-31. PubMed ID: 20799452
[No Abstract] [Full Text] [Related]
4. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
Wolthers OD; Høst A; Frederiksen B; Halken S
Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
[TBL] [Abstract][Full Text] [Related]
5. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M
J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
[TBL] [Abstract][Full Text] [Related]
6. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
Witten M; Malling HJ; Blom L; Poulsen BC; Poulsen LK
J Allergy Clin Immunol; 2013 Nov; 132(5):1248-1252.e5. PubMed ID: 24035151
[No Abstract] [Full Text] [Related]
7. Oral reactions to sublingual immunotherapy: a bioptic study.
Marcucci F; Sensi L; Incorvaia C; Di Cara G; Moingeon P; Frati F
Allergy; 2007 Dec; 62(12):1475-7. PubMed ID: 17983387
[No Abstract] [Full Text] [Related]
8. Sublingual immunotherapy.
Corrigan C
J Allergy Clin Immunol; 2007 Feb; 119(2):515; author reply 515-7. PubMed ID: 17187850
[No Abstract] [Full Text] [Related]
9. Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen.
Rondón C; Blanca-López N; Aranda A; Herrera R; Rodriguez-Bada JL; Canto G; Mayorga C; Torres MJ; Campo P; Blanca M
J Allergy Clin Immunol; 2011 Apr; 127(4):1069-71. PubMed ID: 21277626
[No Abstract] [Full Text] [Related]
10. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
Ohashi Y
Arerugi; 2008 May; 57(5):519-23. PubMed ID: 18520172
[No Abstract] [Full Text] [Related]
11. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis.
Agostinis F; Forti S; Di Berardino F
Allergy; 2010 Mar; 65(3):410-1. PubMed ID: 19804450
[No Abstract] [Full Text] [Related]
12. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy: allergen specific or placebo effect?
Kette F; Smith W
J Allergy Clin Immunol; 2011 Aug; 128(2):430; author reply 430-2. PubMed ID: 21665261
[No Abstract] [Full Text] [Related]
15. Grazax sublingual immunotherapy in pre-co-seasonal and continuous treatment regimens: is there a difference in clinical efficacy?
Nakonechna A; Hills J; Moor J; Dore P; Abuzakouk M
Ann Allergy Asthma Immunol; 2015 Jan; 114(1):73-4. PubMed ID: 25457868
[No Abstract] [Full Text] [Related]
16. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
Worm M
Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous SCIT with 2 separate allergen extracts demonstrates comparable safety compared to SCIT with a single allergen extract.
Röder A; Darrelmann N; Klingenberg W; Krüll M; Suttorp N; Noga O
J Investig Allergol Clin Immunol; 2009; 19(6):512-3. PubMed ID: 20128433
[No Abstract] [Full Text] [Related]
18. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
Nichani JR; de Carpentier J
J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
20. Rush immunotherapy with sublingual administration of grass allergen extract.
Feliziani V; Marfisi RM; Parmiani S
Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
